Chronic Chikungunya Virus Disease.
Journal
Current topics in microbiology and immunology
ISSN: 0070-217X
Titre abrégé: Curr Top Microbiol Immunol
Pays: Germany
ID NLM: 0110513
Informations de publication
Date de publication:
2022
2022
Historique:
pubmed:
19
1
2019
medline:
5
2
2022
entrez:
19
1
2019
Statut:
ppublish
Résumé
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that has caused both small- and large-scale epidemics of incapacitating musculoskeletal disease across the globe. A substantial proportion of infected individuals experience debilitating arthralgia and/or arthritis that can persist in relapsing or continuous forms for months to years, an occurrence that appears independent of viral strain and outbreak location. Due to the lack of CHIKV-specific vaccine or therapeutics, treatment of chronic CHIKV disease is limited to supportive care. Although the epidemiologic and molecular mechanisms that dictate resolution or chronicity of CHIKV disease remain unclear, several risk factors and immunological responses have been implicated in the development of chronic CHIKV disease. Mounting evidence from animal models and limited case studies indicates that chronic disease is likely a result of induced autoimmunity and/or viral persistence in joint-associated tissue. Due to the global spread and explosive, often unpredictable nature of CHIKV epidemics, concerted efforts to obtain a more precise understanding of the development and maintenance of chronic CHIKV disease must be at the forefront of investigative endeavors.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
55-80Informations de copyright
© 2018. Springer Nature Switzerland AG.
Références
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581. https://doi.org/10.1002/art.27584
doi: 10.1002/art.27584
Blettery M, Brunier L, Polomat K, Moinet F, Deligny C, Arfi S, Jean-Baptiste G, De Bandt M (2016) Brief report: management of chronic post-chikungunya rheumatic disease: the Martinican experience: chronic post-chikungunya rheumatic disease. Arthritis Rheumatol 68:2817–2824. https://doi.org/10.1002/art.39775
doi: 10.1002/art.39775
pubmed: 27273928
Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, Arvin-Berod C, Paganin F (2008) Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on Reunion Island. Clin Infect Dis 47:469–475. https://doi.org/10.1086/590003
doi: 10.1086/590003
pubmed: 18611153
Bouquillard É, Combe B (2009) A report of 21 cases of rheumatoid arthritis following chikungunya fever. A mean follow-up of two years. Joint Bone Spine 76:654–657. https://doi.org/10.1016/j.jbspin.2009.08.005
doi: 10.1016/j.jbspin.2009.08.005
pubmed: 19945329
Bouquillard E, Fianu A, Bangil M, Charlette N, Ribéra A, Michault A, Favier F, Simon F, Flipo R-M (2017) Rheumatic manifestations associated with Chikungunya virus infection: A study of 307 patients with 32-month follow-up (Rhumatochik study). Joint Bone Spine. https://doi.org/10.1016/j.jbspin.2017.01.014
Brighton SW, Prozesky OW, de la Harpe AL (1983) Chikungunya virus infection. A retrospective study of 107 cases. South Afr Med J Suid-Afr Tydskr Vir Geneeskd 63:313–315
Carey DE (1971) Chikungunya and dengue: a case of mistaken identity? J Hist Med Allied Sci 26:243–262
doi: 10.1093/jhmas/XXVI.3.243
Carey DE, Myers RM, DeRanitz CM, Jadhav M, Reuben R (1969) The 1964 chikungunya epidemic at Vellore, South India, including observations on concurrent dengue. Trans R Soc Trop Med Hyg 63:434–445
doi: 10.1016/0035-9203(69)90030-3
Chopra A, Anuradha V, Ghorpade R, Saluja M (2012) Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect 140:842–850. https://doi.org/10.1017/S0950268811001300
Chopra A, Anuradha V, Lagoo-Joshi V, Kunjir V, Salvi S, Saluja M (2008) Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum 58:2921–2922. https://doi.org/10.1002/art.23753
doi: 10.1002/art.23753
pubmed: 18759351
Chopra A, Saluja M, Venugopalan A (2014) Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol 66:319–326. https://doi.org/10.1002/art.38221
doi: 10.1002/art.38221
pubmed: 24504804
Chow A, Her Z, Ong EKS, Chen J, Dimatatac F, Kwek DJC, Barkham T, Yang H, Rénia L, Leo Y-S, Ng LFP (2011) Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203:149–157. https://doi.org/10.1093/infdis/jiq042
doi: 10.1093/infdis/jiq042
pubmed: 21288813
pmcid: 3071069
Couturier E, Guillemin F, Mura M, Léon L, Virion J-M, Letort M-J, De Valk H, Simon F, Vaillant V (2012) Impaired quality of life after chikungunya virus infection: a 2-year follow-up study. Rheumatology 51:1315–1322. https://doi.org/10.1093/rheumatology/kes015
doi: 10.1093/rheumatology/kes015
pubmed: 22427407
De Ranitz CM, Myers RM, Varkey MJ, Isaac ZH, Carey DE (1965) Clinical impressions of chikungunya in Vellore gained from study of adult patients. Indian J Med Res 53:756–763
pubmed: 5830409
Dougados M, Linden SVD, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G, Veys E, Zeidler H (1991) The European spondyloarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227. https://doi.org/10.1002/art.1780341003
doi: 10.1002/art.1780341003
pubmed: 1930310
Elsinga J, Gerstenbluth I, van der Ploeg S, Halabi Y, Lourents NT, Burgerhof JG, van der Veen HT, Bailey A, Grobusch MP, Tami A (2017) Long-term Chikungunya Sequelae in Curaçao: Burden, Determinants, and a Novel Classification Tool. J Infect Dis 216:573–581. https://doi.org/10.1093/infdis/jix312
Essackjee K, Goorah S, Ramchurn SK, Cheeneebash J, Walker-Bone K (2013) Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus. Postgrad Med J 89:440–447. https://doi.org/10.1136/postgradmedj-2012-131477
doi: 10.1136/postgradmedj-2012-131477
pubmed: 23645664
Feldstein LR, Rowhani-Rahbar A, Staples JE, Weaver MR, Halloran ME, Ellis EM (2017) Persistent arthralgia associated with chikungunya virus outbreak, US Virgin Islands, December 2014–February 2016. Emerg Infect Dis 23:673–676. https://doi.org/10.3201/eid2304.161562
doi: 10.3201/eid2304.161562
pubmed: 28322703
pmcid: 5367425
Foissac M, Javelle E, Ray S, Guerin B, Simon F (2015) Post-chikungunya rheumatoid arthritis, saint martin. Emerg Infect Dis 21:530–532. https://doi.org/10.3201/eid2103.141397
doi: 10.3201/eid2103.141397
pubmed: 25695499
pmcid: 4344282
Fourie ED, Morrison JG (1979) Rheumatoid arthritic syndrome after chikungunya fever. South Afr Med J 56:130–132
Ganu MA, Ganu AS (2011) Post-chikungunya chronic arthritis—our experience with DMARDs over two year follow up. J Assoc Physicians India 59:83–86
pubmed: 21751641
Gear J, Reid FP (1957) The occurrence of a dengue-like fever in the North-Eastern Transvaal. I. Clinical features and isolation of virus. South Afr Med J Suid-Afr Tydskr Vir Geneeskd 31:253–257
Gérardin P, Fianu A, Malvy D, Mussard C, Boussaïd K, Rollot O, Michault A, Gaüzere B-A, Bréart G, Favier F (2011) Perceived morbidity and community burden after a chikungunya outbreak: the TELECHIK survey, a population-based cohort study. BMC Med 9:5. https://doi.org/10.1186/1741-7015-9-5
doi: 10.1186/1741-7015-9-5
pubmed: 21235760
pmcid: 3029216
Gérardin P, Fianu A, Michault A, Mussard C, Boussaïd K, Rollot O, Grivard P, Kassab S, Bouquillard E, Borgherini G, Gaüzère B-A, Malvy D, Bréart G, Favier F (2013) Predictors of chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther 15:R9. https://doi.org/10.1186/ar4137
doi: 10.1186/ar4137
pubmed: 23302155
pmcid: 3672753
Grandadam M, Caro V, Plumet S, Thiberge J-M, Souarès Y, Failloux A-B, Tolou HJ, Budelot M, Cosserat D, Leparc-Goffart I, Desprès P (2011) Chikungunya virus, Southeastern France. Emerg Infect Dis 17:910–913. https://doi.org/10.3201/eid1705.101873
doi: 10.3201/eid1705.101873
pubmed: 21529410
pmcid: 3321794
Halstead SB, Scanlon JE, Umpaivit P, Udomsakdi S (1969a) Dengue and chikungunya virus infection in man in Thailand, 1962–1964. IV. Epidemiologic studies in the Bangkok Metropolitan area. Am J Trop Med Hyg 18:997–1021. https://doi.org/10.4269/ajtmh.1969.18.997
doi: 10.4269/ajtmh.1969.18.997
pubmed: 4390977
Halstead SB, Udomsakdi S, Scanlon JE, Rohitayodhin S (1969b) Dengue and chikungunya virus infection in man in Thailand, 1962–1964. V. Epidemiologic observations outside Bangkok. Am J Trop Med Hyg 18:1022–1033. https://doi.org/10.4269/ajtmh.1969.18.1022
doi: 10.4269/ajtmh.1969.18.1022
pubmed: 4390976
Hawman DW, Stoermer KA, Montgomery SA, Pal P, Oko L, Diamond MS, Morrison TE (2013) Chronic joint disease caused by persistent chikungunya virus infection is controlled by the adaptive immune response. J Virol 87:13878–13888. https://doi.org/10.1128/JVI.02666-13
doi: 10.1128/JVI.02666-13
pubmed: 24131709
pmcid: 3838294
Hawman DW, Fox JM, Ashbrook AW, May NA, Schroeder KMS, Torres RM, Crowe JE Jr, Dermody TS, Diamond MS, Morrison TE (2016) Pathogenic chikungunya virus evades B cell Responses to establish persistence. Cell Rep 16:1326–1338. https://doi.org/10.1016/j.celrep.2016.06.076
doi: 10.1016/j.celrep.2016.06.076
pubmed: 27452455
pmcid: 5003573
Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, Denizot M, Guichard E, Ribera A, Henni T, Tallet F, Moiton MP, Gauzere BA, Bruniquet S, Jaffar Bandjee Z, Morbidelli P, Martigny G, Jolivet M, Gay F, Grandadam M, Tolou H, Vieillard V, Debre P, Autran B, Gasque P (2010) Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 184:5914–5927. https://doi.org/10.4049/jimmunol.0900255
doi: 10.4049/jimmunol.0900255
pubmed: 20404278
Hoarau J-J, Gay F, Pellé O, Samri A, Jaffar-Bandjee M-C, Gasque P, Autran B (2013) Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005–2006 in La Reunion Island. PLoS ONE 8:e84695
doi: 10.1371/journal.pone.0084695
Javelle E, Ribera A, Degasne I, Gaüzère B-A, Marimoutou C, Simon F (2015) Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006–2012. PLoS Negl Trop Dis 9:e0003603. https://doi.org/10.1371/journal.pntd.0003603
doi: 10.1371/journal.pntd.0003603
pubmed: 25760632
pmcid: 4356515
Kam Y-W, Simarmata D, Chow A, Her Z, Teng T-S, Ong EKS, Rénia L, Leo Y-S, Ng LFP (2012) Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J Infect Dis 205:1147–1154. https://doi.org/10.1093/infdis/jis033
doi: 10.1093/infdis/jis033
pubmed: 22389226
pmcid: 3295607
Kelvin AA, Banner D, Silvi G, Moro ML, Spataro N, Gaibani P, Cavrini F, Pierro A, Rossini G, Cameron MJ, Bermejo-Martin JF, Paquette SG, Xu L, Danesh A, Farooqui A, Borghetto I, Kelvin DJ, Sambri V, Rubino S (2011) Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis 5:e1279. https://doi.org/10.1371/journal.pntd.0001279
doi: 10.1371/journal.pntd.0001279
pubmed: 21858242
pmcid: 3156690
Kennedy AC, Fleming J, Solomon L (1980) Chikungunya viral arthropathy: a clinical description. J Rheumatol 7:231–236
pubmed: 7373626
Kularatne SAM, Weerasinghe SC, Gihan C, Wickramasinghe S, Dharmarathne S, Abeyrathna A, Jayalath T (2012) Epidemiology, Clinical Manifestations, and Long-Term Outcomes of a Major Outbreak of Chikungunya in a Hamlet in Sri Lanka, in 2007: A Longitudinal Cohort Study. J Trop Med 2012:1–6. https://doi.org/10.1155/2012/639178
Kulkarni SP, Ganu M, Jayawant P, Thanapati S, Ganu A, Tripathy AS (2017) Regulatory T cells and IL-10 as modulators of chikungunya disease outcome: a preliminary study. Eur J Clin Microbiol Infect Dis, 1–7. https://doi.org/10.1007/s10096-017-3087-4
Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, Guigand L, Dubreil L, Lebon P, Verrier B, de Lamballerie X, Suhrbier A, Cherel Y, Le Grand R, Roques P (2010) Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 120:894–906. https://doi.org/10.1172/JCI40104
doi: 10.1172/JCI40104
pubmed: 20179353
pmcid: 2827953
Larrieu S, Pouderoux N, Pistone T, Filleul L, Receveur M-C, Sissoko D, Ezzedine K, Malvy D (2010) Factors associated with persistence of arthralgia among chikungunya virus-infected travellers: report of 42 French cases. J Clin Virol 47:85–88. https://doi.org/10.1016/j.jcv.2009.11.014
doi: 10.1016/j.jcv.2009.11.014
pubmed: 20004145
Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X (2014) Chikungunya in the Americas. The Lancet 383:514. https://doi.org/10.1016/S0140-6736(14)60185-9
doi: 10.1016/S0140-6736(14)60185-9
Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, Sudeep AB, Muruganandam N, Chaitanya IK, Guruprasad DR (2010) Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 104:392–399. https://doi.org/10.1016/j.trstmh.2010.01.011
doi: 10.1016/j.trstmh.2010.01.011
pubmed: 20171708
Marimoutou C, Ferraro J, Javelle E, Deparis X, Simon F (2015) Chikungunya infection: self-reported rheumatic morbidity and impaired quality of life persist 6 years later. Clin Microbiol Infect 21:688–693. https://doi.org/10.1016/j.cmi.2015.02.024
doi: 10.1016/j.cmi.2015.02.024
pubmed: 25752222
Marimoutou C, Vivier E, Oliver M, Boutin J-P, Simon F (2012) Morbidity and Impaired Quality of Life 30 Months After Chikungunya Infection: Comparative Cohort of Infected and Uninfected French Military Policemen in Reunion Island. Medicine 91:212–219. https://doi.org/10.1097/MD
Marques CDL, Duarte ALBP, Ranzolin A, Dantas AT, Cavalcanti NG, Gonçalves RSG, Junior LF da R, Valadares LD de A, Melo AKG de, Freire EAM, Teixeira R, Neto FAB, Medeiros MM das C, Carvalho JF de, Santos MSF, Océa RA de LC, Levy RA, Andrade CAF de, Pinheiro G da RC, Abreu MM, Verztman JF, Merenlender S, Ribeiro SLE, Costa IP da, Pileggi G, Trevisani VFM, Lopes MIB, Brito C, Figueiredo E, Queiroga F, Feitosa T, Tenório A da S, Siqueira GR de, Paiva R, Vasconcelos JTS, Christopoulos G (2017) Recommendations of the Brazilian Society of Rheumatology for the diagnosis and treatment of chikungunya fever. Part 2—Treatment. Rev Bras Reumatol Engl Ed. https://doi.org/10.1016/j.rbre.2017.06.004
Mathew AJ, Goyal V, George E, Thekkemuriyil DV, Jayakumar B, Chopra A, On behalf of the Trivandrum COPCORD Study Group (2011) Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a chikungunya viral epidemic in south India: a population based observational study. Int J Clin Pract 65:1306–1312. https://doi.org/10.1111/j.1742-1241.2011.02792.x
McCarthy MK, Morrison TE (2017) Persistent RNA virus infections: do PAMPS drive chronic disease? Curr Opin Virol 23:8–15. https://doi.org/10.1016/j.coviro.2017.01.003
doi: 10.1016/j.coviro.2017.01.003
pubmed: 28214732
pmcid: 5474173
Messaoudi I, Vomaske J, Totonchy T, Kreklywich CN, Haberthur K, Springgay L, Brien JD, Diamond MS, DeFilippis VR, Streblow DN (2013) Chikungunya virus infection results in higher and persistent viral replication in aged Rhesus macaques due to defects in anti-viral immunity. PLoS Negl Trop Dis 7:e2343. https://doi.org/10.1371/journal.pntd.0002343
doi: 10.1371/journal.pntd.0002343
pubmed: 23936572
pmcid: 3723534
Miner JJ, Aw Yeang HX, Fox JM, Taffner S, Malkova ON, Oh ST, Kim AHJ, Diamond MS, Lenschow DJ, Yokoyama WM (2015) Brief report: chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol 67:1214–1220. https://doi.org/10.1002/art.39027
doi: 10.1002/art.39027
pubmed: 25605621
pmcid: 4591551
Mogami R, de Almeida Vieira A, Junqueira Filho EA, Lopes AJ (2017a) Chikungunya fever outbreak in Rio de Janeiro, Brazil: ultrasonographic aspects of musculoskeletal complications. J Clin Ultrasound 45:43–44. https://doi.org/10.1002/jcu.22394
doi: 10.1002/jcu.22394
pubmed: 27619412
Mogami R, Pereira Vaz JL, de Fátima Barcelos Chagas Y, de Abreu MM, Torezani RS, de Almeida Vieira A, Junqueira Filho EA, Barbosa YB, Carvalho ACP, Lopes AJ (2017b) Ultrasonography of hands and wrists in the diagnosis of complications of chikungunya fever. J Ultrasound Med. https://doi.org/10.1002/jum.14344
Mogami R, Vaz JLP, Chagas Y de FB, Torezani RS, Vieira A de A, Koifman ACB, Barbosa YB, de Abreu MM (2017c) Ultrasound of ankles in the diagnosis of complications of chikungunya fever. Radiol Bras 50:71–75. https://doi.org/10.1590/0100-3984.2016.0221
Moore DL, Reddy S, Akinkugbe FM, Lee VH, David-West TS, Causey OR, Carey DE (1974) An epidemic of chikungunya fever at Ibadan, Nigeria, 1969. Ann Trop Med Parasitol 68:59–68
doi: 10.1080/00034983.1974.11686925
Moro ML, Gagliotti C, Silvi G, Angelini R, Sambri V, Rezza G, Massimiliani E, Mattivi A, Grilli E, Finarelli AC, Spataro N, Pierro AM, Seyler T, Macini P (2010) Chikungunya virus in North-Eastern Italy: a seroprevalence survey. Am J Trop Med Hyg 82:508–511. https://doi.org/10.4269/ajtmh.2010.09-0322
doi: 10.4269/ajtmh.2010.09-0322
pubmed: 20207883
pmcid: 2829919
Moro ML, Grilli E, Corvetta A, Silvi G, Angelini R, Mascella F, Miserocchi F, Sambo P, Finarelli AC, Sambri V, Gagliotti C, Massimiliani E, Mattivi A, Pierro AM, Macini P (2012) Long-term chikungunya infection clinical manifestations after an outbreak in Italy: A prognostic cohort study. J Infect 65:165–172. https://doi.org/10.1016/j.jinf.2012.04.005
doi: 10.1016/j.jinf.2012.04.005
pubmed: 22522292
Murillo-Zamora E, Mendoza-Cano O, Trujillo-Hernández B, Alberto Sánchez-Piña R, Guzmán-Esquivel J (2017) Persistent arthralgia and related risks factors in laboratory-confirmed cases of chikungunya virus infection in Mexico. Rev Panam Salud Pública 41
Muyembe-Tamfum JJ, Peyrefitte CN, Yogolelo R, Mathina Basisya E, Koyange D, Pukuta E, Mashako M, Tolou H, Durand JP (2003) Epidemic of chikungunya virus in 1999 and 200 in the democratic republic of the Congo. Med Trop Rev Corps Sante Colon 63:637–638
Myers RM, Carey DE, Reuben R, Jesudass ES, De Ranitz C, Jadhav M (1965) The 1964 epidemic of dengue-like fever in South India: isolation of chikungunya virus from human sera and from mosquitoes. Indian J Med Res 53:694–701
pubmed: 5830403
Nakaya HI, Gardner J, Poo Y-S, Major L, Pulendran B, Suhrbier A (2012) Gene profiling of chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis. Arthritis Rheum 64:3553–3563. https://doi.org/10.1002/art.34631
doi: 10.1002/art.34631
pubmed: 22833339
Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M (2001) Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 97:1920–1924. https://doi.org/10.1182/blood.V97.7.1920
doi: 10.1182/blood.V97.7.1920
pubmed: 11264152
Ozden S, Huerre M, Riviere J-P, Coffey LL, Afonso PV, Mouly V, de Monredon J, Roger J-C, Amrani ME, Yvin J-L, Jaffar M-C, Frenkiel M-P, Sourisseau M, Schwartz O, Butler-Browne G, Desprès P, Gessain A, Ceccaldi P-E (2007) Human muscle satellite cells as targets of chikungunya virus infection. PLoS ONE 2:e527. https://doi.org/10.1371/journal.pone.0000527
doi: 10.1371/journal.pone.0000527
pubmed: 17565380
pmcid: 1885285
PAHO WHO | Chikungunya. http://www.paho.org/hq/index.php?option=com_topics&view=article&id=343&Itemid=40931&lang=en . Accessed 29 Nov 2017
Petersen LR, Powers AM (2016) Chikungunya: epidemiology. F1000Research. https://doi.org/10.12688/f1000research.7171.1
Poo YS, Rudd PA, Gardner J, Wilson JAC, Larcher T, Colle M-A, Le TT, Nakaya HI, Warrilow D, Allcock R, Bielefeldt-Ohmann H, Schroder WA, Khromykh AA, Lopez JA, Suhrbier A (2014) Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection. PLoS Negl Trop Dis 8:e3354. https://doi.org/10.1371/journal.pntd.0003354
doi: 10.1371/journal.pntd.0003354
pubmed: 25474568
pmcid: 4256279
Powers AM, Logue CH (2007) Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 88:2363–2377. https://doi.org/10.1099/vir.0.82858-0
doi: 10.1099/vir.0.82858-0
pubmed: 17698645
Rahim AA, Thekkekara RJ, Bina T, Paul BJ (2016) Disability with persistent pain following an epidemic of chikungunya in rural South India. J Rheumatol 43:440–444. https://doi.org/10.3899/jrheum.141609
doi: 10.3899/jrheum.141609
pubmed: 26669921
Ramachandran V, Kaur P, Kanagasabai K, Vadivoo S, Murhekar MV (2014) Persistent arthralgia among Chikungunya patients and associated risk factors in Chennai, South India. J Postgrad Med 60:3. https://doi.org/10.4103/0022-3859.128795
Ravi V (2006) Re-emergence of chikungunya virus in India. Indian J Med Microbiol, 83–84
Ravindran V, Alias G (2017) Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study. Clin Rheumatol 36:1335–1340. https://doi.org/10.1007/s10067-016-3429-0
doi: 10.1007/s10067-016-3429-0
pubmed: 27699657
Renault P, Solet J-L, Sissoko D, Balleydier E, Larrieu S, Filleul L, Lassalle C, Thiria J, Rachou E, de Valk H et al (2007) A major epidemic of chikungunya virus infection on Reunion Island, France, 2005–2006. Am J Trop Med Hyg 77:727–731
doi: 10.4269/ajtmh.2007.77.727
Robinson MC (1955) An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953. I. Clinical features. Trans R Soc Trop Med Hyg 49:28–32. https://doi.org/10.1016/0035-9203(55)90080-8
doi: 10.1016/0035-9203(55)90080-8
pubmed: 14373834
Rodriguez-Morales AJ, Restrepo-Posada VM, Acevedo-Escalante N, Rodríguez-Muñoz ED, Valencia-Marín M, Castrillón-Spitia JD, Londoño JJ, Bedoya-Rendón HD, Cárdenas-Pérez J de J, Cardona-Ospina JA, Lagos-Grisales GJ (2017) Impaired quality of life after chikungunya virus infection: a 12-month follow-up study of its chronic inflammatory rheumatism in La Virginia, Risaralda, Colombia. Rheumatol Int, 1–2. https://doi.org/10.1007/s00296-017-3795-1
Rodríguez-Morales AJ, Cardona-Ospina JA, Fernanda Urbano-Garzón S, Sebastian Hurtado-Zapata J (2016a) Prevalence of post-chikungunya infection chronic inflammatory arthritis: a systematic review and meta-analysis: chronic inflammatory rheumatism following chikungunya. Arthritis Care Res 68:1849–1858. https://doi.org/10.1002/acr.22900
doi: 10.1002/acr.22900
Rodríguez-Morales AJ, Villamil-Gomez W, Merlano-Espinosa M, Simone-Kleber L (2016b) Post-chikungunya chronic arthralgia: a first retrospective follow-up study of 39 cases in Colombia. Clin Rheumatol 35:831–832. https://doi.org/10.1007/s10067-015-3041-8
doi: 10.1007/s10067-015-3041-8
pubmed: 26242471
Ross RW (1956) The Newala epidemic. III. The virus: Isolation, Pathogenic Properties and Relationship to the Epidemic. J Hyg (Lond) 54:177–191
doi: 10.1017/S0022172400044442
Saluzzo JF, Cornet M, Digoutte JP (1983) Outbreak of a chikungunya virus epidemic in western Senegal in 1982. Dakar Med 28:497–500
pubmed: 6323109
Schilte C, Staikovsky F, Couderc T, Madec Y, Carpentier F, Kassab S, Albert ML, Lecuit M, Michault A (2013) Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis 7:e2137. https://doi.org/10.1371/journal.pntd.0002137
doi: 10.1371/journal.pntd.0002137
pubmed: 23556021
pmcid: 3605278
Sergon K, Njuguna C, Kalani R, Ofula V, Onyango C, Konongoi LS, Bedno S, Burke H, Dumilla AM, Konde J, Njenga MK, Sang R, Breiman RF (2008) Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg 78:333–337
Sergon K, Yahaya AA, Brown J, Bedja SA, Mlindasse M, Agata N, Allaranger Y, Ball MD, Powers AM, Ofula V (2007) Seroprevalence of chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. Am J Trop Med Hyg 76:1189–1193
doi: 10.4269/ajtmh.2007.76.1189
Shah KV, Gibbs CJ, Banerjee G (1964) Virological investigation of the epidemic of haemorrhagic fever in Calcutta: isolation of three strains of chikungunya virus. Indian J Med Res 52:676–683
pubmed: 14195507
Shegarfi H, Naddafi F, Mirshafiey A (2012) Natural killer cells and their role in rheumatoid arthritis: friend or foe? Sci World J 2012:1–10. https://doi.org/10.1100/2012/491974
doi: 10.1100/2012/491974
Simon F, Parola P, Grandadam M, Fourcade S, Oliver M, Brouqui P, Hance P, Kraemer P, Mohamed AA, de Lamballerie X et al (2007) Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore) 86:123–137
doi: 10.1097/MD/0b013e31806010a5
Simon F, Javelle E, Cabie A, Bouquillard E, Troisgros O, Gentile G, Leparc-Goffart I, Hoen B, Gandjbakhch F, Rene-Corail P, Franco J-M, Caumes E, Combe B, Poiraudeau S, Gane-Troplent F, Djossou F, Schaerverbeke T, Criquet-Hayot A, Carrere P, Malvy D, Gaillard P, Wendling D (2015) French guidelines for the management of chikungunya (acute and persistent presentations). November 2014. Médecine Mal Infect 45:243–263. https://doi.org/10.1016/j.medmal.2015.05.007
doi: 10.1016/j.medmal.2015.05.007
Sissoko D, Malvy D, Giry C, Delmas G, Paquet C, Gabrie P, Pettinelli F, Sanquer MA, Pierre V (2008) Outbreak of chikungunya fever in Mayotte, Comoros archipelago, 2005–2006. Trans R Soc Trop Med Hyg 102:780–786. https://doi.org/10.1016/j.trstmh.2008.02.018
doi: 10.1016/j.trstmh.2008.02.018
pubmed: 18400240
Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, Pierre V (2009) Post-epidemic chikungunya disease on Reunion Island: course of Rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis 3:e389. https://doi.org/10.1371/journal.pntd.0000389
doi: 10.1371/journal.pntd.0000389
pubmed: 19274071
pmcid: 2647734
Staikowsky F, Roux KL, Schuffenecker I, Laurent P, Grivard P, Develay A, Michault A (2008) Retrospective survey of chikungunya disease in Réunion Island hospital staff. Epidemiol Amp Infect 136:196–206. https://doi.org/10.1017/S0950268807008424
doi: 10.1017/S0950268807008424
Teo T-H, Lum F-M, Claser C, Lulla V, Lulla A, Merits A, Renia L, Ng LFP (2013) A Pathogenic Role for CD4+ T Cells during chikungunya virus infection in mice. J Immunol 190:259–269. https://doi.org/10.4049/jimmunol.1202177
doi: 10.4049/jimmunol.1202177
pubmed: 23209328
Thanapati S, Ganu M, Giri P, Kulkarni S, Sharma M, Babar P, Ganu A, Tripathy AS (2017) Impaired NK cell functionality and increased TNF-α production as biomarkers of chronic chikungunya arthritis and rheumatoid arthritis. Hum Immunol 78:370–374. https://doi.org/10.1016/j.humimm.2017.02.006
doi: 10.1016/j.humimm.2017.02.006
pubmed: 28213049
Thiberville S-D, Moyen N, Dupuis-Maguiraga L, Nougairede A, Gould EA, Roques P, de Lamballerie X (2013) Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res 99:345–370. https://doi.org/10.1016/j.antiviral.2013.06.009
doi: 10.1016/j.antiviral.2013.06.009
pubmed: 23811281
pmcid: 7114207
Tomori O, Fagbami A, Fabiyi A (1975) The 1974 epidemic of chikungunya fever in children in Ibadan. Trop Geogr Med 27:413–417
pubmed: 1216323
Uhrlaub JL, Pulko V, DeFilippis VR, Broeckel R, Streblow DN, Coleman GD, Park BS, Lindo JF, Vickers I, Anzinger JJ, Nikolich-Žugich J (2016) Dysregulated TGF-β production underlies the age-related vulnerability to chikungunya virus. PLoS Pathog 12:e1005891. https://doi.org/10.1371/journal.ppat.1005891
doi: 10.1371/journal.ppat.1005891
pubmed: 27736984
pmcid: 5063327
van Aalst M, Nelen CM, Goorhuis A, Stijnis C, Grobusch MP (2017) Long-term sequelae of chikungunya virus disease: a systematic review. Travel Med Infect Dis 15:8–22. https://doi.org/10.1016/j.tmaid.2017.01.004
doi: 10.1016/j.tmaid.2017.01.004
pubmed: 28163198
Venugopalan A, Ghorpade RP, Chopra A (2014) Cytokines in acute chikungunya. PLOS ONE 9:e111305. https://doi.org/10.1371/journal.pone.0111305
doi: 10.1371/journal.pone.0111305
pubmed: 25343623
pmcid: 4208842
Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM (2011) The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis 204:115–123. https://doi.org/10.1093/infdis/jiq006
doi: 10.1093/infdis/jiq006
pubmed: 21628665
Waymouth HE, Zoutman DE, Towheed TE (2013) Chikungunya-related arthritis: case report and review of the literature. Semin Arthritis Rheum 43:273–278. https://doi.org/10.1016/j.semarthrit.2013.03.003
doi: 10.1016/j.semarthrit.2013.03.003
pubmed: 23608542
Win MK, Chow A, Dimatatac F, Go CJ, Leo YS (2010) Chikungunya fever in Singapore: acute clinical and laboratory features, and factors associated with persistent arthralgia. J Clin Virol 49:111–114. https://doi.org/10.1016/j.jcv.2010.07.004
doi: 10.1016/j.jcv.2010.07.004
pubmed: 20674479
Yaseen HM, Simon F, Deparis X, Marimoutou C (2014) Identification of initial severity determinants to predict arthritis after chikungunya infection in a cohort of French gendarmes. BMC Musculoskelet Disord 15:249. https://doi.org/10.1186/1471-2474-15-249
doi: 10.1186/1471-2474-15-249
pubmed: 25059583
pmcid: 4121301
Zim MA, Sam I-C, Omar SFS, Chan YF, AbuBakar S, Kamarulzaman A (2013) Chikungunya infection in Malaysia: comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol 56:141–145. https://doi.org/10.1016/j.jcv.2012.10.019
doi: 10.1016/j.jcv.2012.10.019